Key facts
- Laxmi Therapeutic Devices’s last known valuation is $35.0M (Feb 2025).
- It has raised $58.2M across 8 recorded rounds; the latest was Early Stage VC ($15.0M) in Jul 2024.
- Notable investors include California NanoSystems Institute, Pasadena Bio, U.S. Department of Health and Human Services.
- Laxmi Therapeutic Devices has filed 15 Form Ds with the SEC since 2016, most recently Feb 2025 ($15.0M sold to 5 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 8 rounds
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Laxmi Therapeutic Devices
Funding rounds
8 roundsAbout Laxmi Therapeutic Devices
Developer of wearable diagnostic devices designed to allow daily continuous glucose monitoring. The company's painless patch technology specializes in integration with multiple microneedles that help in glucose monitoring, enabling people living with type I diabetes to manage their lives by getting insulin control to treat diabetes.
- Sector
- Healthcare
- HQ
- Goleta, CA, United States
- Founded
- 2016
- Employees
- 28
- Website
- laxmitherapeuticdevices.com/
- Ownership
- Privately Held (backing)
Laxmi Therapeutic Devices doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Laxmi Therapeutic Devices shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Laxmi Therapeutic Devices in its N-PORT filings yet. We sweep new filings monthly.